During weeks 12-19 of 2020, the incidence of end-stage kidney disease decreased 20% compared with the same period in 2017-2019, according to a COVID-19 supplement to the US Renal Data System 2020 annual data report.
Patients with multiple myeloma on dialysis who are undergoing autologous stem cell transplantation are at an increased risk for inpatient mortality.
Rates of peritonitis among patients on peritoneal dialysis, in episodes per patient-year, varied from 0.40 in Thailand to 0.26 in the United States, a study found.
Dialysis decision regret less likely for those who discuss prognosis with doctors, complete living will.
In a study of dialysis patients with new-onset nonvalvular atrial fibrillation, investigators found a nearly 3-fold higher incidence of fatal or intracranial bleeding among patients who took apixaban compared with those who received no treatment.
In a study of dialysis patients in Taiwan, hemodialysis patients had a greater risk for acute myocardial infarction than peritoneal dialysis patients.
In an early case series from a New York hospital, nearly 31% of patients with end-stage kidney disease with COVID-19 died.
Study findings further support the use of SGLT2 inhibitors in a broad range of patients with type 2 diabetes, according to investigators.
Patients on dialysis are at especially high risk of infection and experiencing severe complications of infection. The pandemic may prompt patients and their physicians to consider the benefits of dialyzing at home.
Clinicians managing patients with AKI should consider the severity of the disease as well as its course, according to researchers.